Skip to main content
. 2021 Jun 2;11:11595. doi: 10.1038/s41598-021-89934-6

Figure 1.

Figure 1

Expression of mitochondrial genes predict survival in ovarian cancer patients. (A) Kaplan Meier Plotter (KMPlot.org) survival analysis of patients with ovarian cancer exhibiting low (n = 454) or high (n = 160) gene expression for a key component of mitochondrial metabolism, the mitochondrial pyruvate carrier 2 (MPC2) gene. (B) Hazard ratios (HR) from Kaplan Meier survival analysis shown as forest plots for genes encoding subunits of the mitochondrial respiratory chain complexes I, (C) II, (D) III, (E) IV, (F) V, and (G) and mtDNA-related genes. (H) Summary of results illustrating the proportion of significant subunits in previous analysis relative to results from a randomly selected group of 200 genes. Shown are mean HR with 95% C.I. established based on the optimal cutoff; n = 614–1435 for each gene. Filled symbols are significant based on the 95% C.I.